Ranibizumab Injection [Lucentis]

DRUG7 trials

Conditions

Branch Retinal Vein Occlusion with Macular EdemaCataract DiabeticDiabetesDiabetic Macular EdemaDiabetic RetinopathyExudative Age Related Macular DegenerationMild Non-proliferative Diabetic RetinopathyNeovascular Age-related Macular Degeneration

Early Phase 1

Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents

RecruitingNCT06205979

Sohag UniversityDiabetic Macular Edema

Start: 2023-12-12End: 2024-06-14Target: 50Updated: 2024-01-16

Phase 2

Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF

CompletedNCT03071055

Southeast Clinical Research Associates, LLCExudative Age Related Macular Degeneration

Start: 2017-10-01End: 2019-06-03Updated: 2020-10-22

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

WithdrawnNCT03784443

Imperial College LondonDiabetes, Diabetic Macular Edema

Start: 2019-09-01End: 2023-09-01Updated: 2023-10-02

Phase 3

Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation

NCT05138029

Affiliated Hospital of Nantong UniversityDiabetic Retinopathy

Start: 2021-11-15End: 2024-05-31Target: 60Updated: 2023-08-01

TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

Active, not recruitingNCT05461339

BioDlink Biopharm Co., Ltd.Neovascular Age-related Macular Degeneration

Start: 2022-06-28End: 2025-02-28Target: 488Updated: 2025-01-07

Phase 4

Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion

CompletedNCT03709745

St. Erik Eye HospitalBranch Retinal Vein Occlusion with Macular Edema

Start: 2018-10-18End: 2022-07-10Updated: 2024-10-28

Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy

NCT05386160

Ruijin HospitalCataract Diabetic, Diabetic Retinopathy, Mild Non-proliferative Diabetic Retinopathy